127 related articles for article (PubMed ID: 20824514)
1. A preformulation study of a new medicine for Chagas disease treatment: physicochemical characterization, thermal stability, and compatibility of benznidazole.
Soares-Sobrinho JL; de La Roca Soares MF; Lopes PQ; Correia LP; de Souza FS; Macêdo RO; Rolim-Neto PJ
AAPS PharmSciTech; 2010 Sep; 11(3):1391-6. PubMed ID: 20824514
[TBL] [Abstract][Full Text] [Related]
2. Preparation of benznidazole pellets for immediate drug delivery using the extrusion spheronization technique.
Alves-Silva I; Marreto RN; Gelfuso GM; Sá-Barreto LC; Lima EM; Cunha-Filho MS
Drug Dev Ind Pharm; 2017 May; 43(5):762-769. PubMed ID: 27487264
[TBL] [Abstract][Full Text] [Related]
3. A study of photostability and compatibility of the anti-chagas drug Benznidazole with pharmaceutics excipients.
Santos FL; Rolim LA; Figueirêdo CB; Lyra MA; Peixoto MS; Ferraz LR; Soares-Sobrinho JL; Neves de Lima ÁA; Lima Leite AC; Rolim Neto PJ
Drug Dev Ind Pharm; 2015 Jan; 41(1):63-9. PubMed ID: 24134564
[TBL] [Abstract][Full Text] [Related]
4. Risperidone/Randomly Methylated β-Cyclodextrin Inclusion Complex-Compatibility Study with Pharmaceutical Excipients.
Sbârcea L; Tănase IM; Ledeți A; Cîrcioban D; Vlase G; Barvinschi P; Miclău M; Văruţ RM; Suciu O; Ledeți I
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802960
[TBL] [Abstract][Full Text] [Related]
5. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms.
Tiţa B; Fuliaş A; Bandur G; Marian E; Tiţa D
J Pharm Biomed Anal; 2011 Sep; 56(2):221-7. PubMed ID: 21665404
[TBL] [Abstract][Full Text] [Related]
6. Benznidazole microcrystal preparation by solvent change precipitation and in vivo evaluation in the treatment of Chagas disease.
Maximiano FP; de Paula LM; Figueiredo VP; de Andrade IM; Talvani A; Sá-Barreto LC; Bahia MT; Cunha-Filho MS
Eur J Pharm Biopharm; 2011 Aug; 78(3):377-84. PubMed ID: 21397015
[TBL] [Abstract][Full Text] [Related]
7. Development of novel benznidazole formulations: physicochemical characterization and in vivo evaluation on parasitemia reduction in Chagas disease.
Palmeiro-Roldán R; Fonseca-Berzal C; Gómez-Barrio A; Arán VJ; Escario JA; Torrado-Durán S; Torrado-Santiago S
Int J Pharm; 2014 Sep; 472(1-2):110-7. PubMed ID: 24928135
[TBL] [Abstract][Full Text] [Related]
8. Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in paediatric patients.
García MC; Manzo RH; Jimenez-Kairuz AF
Trop Med Int Health; 2015 Jul; 20(7):864-70. PubMed ID: 25784402
[TBL] [Abstract][Full Text] [Related]
9. Benznidazole in vitro dissolution release from a pH-sensitive drug delivery system using Zif-8 as a carrier.
de Moura Ferraz LR; Tabosa AÉGA; da Silva Nascimento DDS; Ferreira AS; Silva JYR; Junior SA; Rolim LA; Rolim-Neto PJ
J Mater Sci Mater Med; 2021 May; 32(6):59. PubMed ID: 33999312
[TBL] [Abstract][Full Text] [Related]
10. Technological innovation strategies for the specific treatment of Chagas disease based on Benznidazole.
Ferraz LRM; Alves AÉG; Nascimento DDSDS; Amariz IAE; Ferreira AS; Costa SPM; Rolim LA; Lima ÁAN; Rolim Neto PJ
Acta Trop; 2018 Sep; 185():127-132. PubMed ID: 29452113
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of benznidazole nano- and microparticles: A new tool for pediatric treatment of Chagas disease?
Seremeta KP; Arrúa EC; Okulik NB; Salomon CJ
Colloids Surf B Biointerfaces; 2019 May; 177():169-177. PubMed ID: 30731393
[TBL] [Abstract][Full Text] [Related]
12. Drug-excipient compatibility studies in formulation development: A case study with benznidazole and monoglycerides.
Saatkamp RH; Dos Santos BM; Sanches MP; Conte J; Rauber GS; Caon T; Parize AL
J Pharm Biomed Anal; 2023 Oct; 235():115634. PubMed ID: 37595356
[TBL] [Abstract][Full Text] [Related]
13. Thermal analysis of the antiretroviral zidovudine (AZT) and evaluation of the compatibility with excipients used in solid dosage forms.
Araújo AA; Storpirtis S; Mercuri LP; Carvalho FM; dos Santos Filho M; Matos JR
Int J Pharm; 2003 Jul; 260(2):303-14. PubMed ID: 12842349
[TBL] [Abstract][Full Text] [Related]
14. Comparative Solid-State Stability of Perindopril Active Substance vs. Pharmaceutical Formulation.
Buda V; Andor M; Ledeti A; Ledeti I; Vlase G; Vlase T; Cristescu C; Voicu M; Suciu L; Tomescu MC
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098840
[TBL] [Abstract][Full Text] [Related]
15. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions.
Figueirêdo CBM; Nadvorny D; Vieira ACQM; Schver GCRM; Soares Sobrinho JL; Rolim Neto PJ; Lee PI; Soares MFR
Eur J Pharm Sci; 2018 Jul; 119():208-218. PubMed ID: 29679707
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical analysis and nonisothermal kinetic study of sertraline-lactose binary mixtures.
Ghaderi F; Nemati M; Siahi-Shadbad MR; Valizadeh H; Monajjemzadeh F
J Food Drug Anal; 2017 Jul; 25(3):709-716. PubMed ID: 28911656
[TBL] [Abstract][Full Text] [Related]
17. Mixture design applied in compatibility studies of catechin and lipid compounds.
Ferreira-Nunes R; Gratieri T; Gelfuso GM; Cunha-Filho M
J Pharm Biomed Anal; 2018 Feb; 149():612-617. PubMed ID: 29202440
[TBL] [Abstract][Full Text] [Related]
18. Compatibility studies between carbamazepine and tablet excipients using thermal and non-thermal methods.
Joshi BV; Patil VB; Pokharkar VB
Drug Dev Ind Pharm; 2002 Jul; 28(6):687-94. PubMed ID: 12149961
[TBL] [Abstract][Full Text] [Related]
19. Thermal analysis applied to verapamil hydrochloride characterization in pharmaceutical formulations.
Yoshida MI; Gomes EC; Soares CD; Cunha AF; Oliveira MA
Molecules; 2010 Apr; 15(4):2439-52. PubMed ID: 20428054
[TBL] [Abstract][Full Text] [Related]
20. Drug-excipient compatibility assessment of solid formulations containing meloxicam.
da Silveira LM; Fiorot AB; Xavier TP; Yoshida MI; de Oliveira MA
Eur J Pharm Sci; 2018 Jan; 112():146-151. PubMed ID: 29174987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
